|

peptide specific dendritic cell Clinical Trials

1 actively recruiting trial

Also known as: Eps8 peptide specific dendritic cell, WT1 peptide specific dendritic cell

Pipeline

Phase 1: 1

Top Sponsors

  • Zhujiang Hospital1

Indications

  • Leukemia, Acute Myelogenous (AML)1
  • Leukemia, Acute Lymphocytic (ALL)1
  • Myelodysplastic Syndromes1
  • Cancer1

Other1 trial

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.